27-28 Eastcastle Street
London W1W 8DH
United Kingdom
https://www.nanosynthgroup.com
Sector(s): Technology
Industry: Scientific & Technical Instruments
Full Time Employees: 15
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Mark Duffin B.E., M.B.A. | Group CEO & Director | 204.7k | N/A | N/A |
Mr. Peter McNamara B.Sc., F.C.A. | Chief Operating Officer | 43.92k | N/A | N/A |
Dr. Gareth WynnVaughan Cave Ph.D. | Chief Scientific Officer & Exec. Director | 51.62k | N/A | 1975 |
Mr. Andrew John Christian Stedman | CFO & Director | N/A | N/A | 1979 |
Ms. Linda Saleh B.Sc. | HR Director | N/A | N/A | N/A |
Nanosynth Group Plc, together with its subsidiaries, focuses on the synthesis and application of nanoparticles. The company offers nanoparticles for animal health and wellbeing, cosmetics, medical, plants, food and drink, functional coatings, and electronics. It also provides anti-viral face masks; and develops anti-pathogenic products. The company was formerly known as Remote Monitored Systems plc and changed its name to Nanosynth Group Plc in August 2021. Nanosynth Group Plc was incorporated in 2014 and is headquartered in London, the United Kingdom.
nanosynth group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.